Categories
Top stories

Development Trends: What Makes Healthcare Supply Chain Management Market Outperforming Its Substitutes?

     

The COVID-19 pandemic is anticipated to impact the global healthcare supply chain management market in an optimistic way. The software system type is expected to be a lucrative segment and is predicted to harvest significant revenue in the global market. The on-premises deliver mode segment is anticipated to dominate the market in terms of revenue generation. Manufacturer end-user is predicted to have rapid growth till 2027. In light of the region, The North America region is anticipated to generate highest revenue in the forecast period.

Due to outbreak of COVID-19 the world is facing an unexpected change and many of the industries are facing tough situations. The COVID-19 outbreak has an optimistic impact on the global healthcare supply chain management market. Healthcare supply chain management includes various process such as obtaining resources, management of supplies, and delivery of goods & services to different providers and patients. Managing supply chain in healthcare is complex procedure and involves fragmented measures. It offers various benefits such as it enhances customer service, reduces operating cost, and enhances financial position.

For instance, supply chain management in healthcare decrease purchasing cost owing to the dependency of retailers on supply chains to deliver expensive products that helps to avoid holding costly inventories in various stores longer than required. Thus it aids to reduce operation cost by cutting purchasing cost, decreasing production cost, and decreases total supply chain cost. During this coronavirus crisis situation, we are helping our clients in understanding the impact of COVID-19 on the global healthcare supply chain management market.

Market Research

According to a new report published by Research Dive, the global healthcare supply chain management market is anticipated to generate revenue of $3.7 billion by the end of the forecast period.

The global healthcare supply chain management market is segmented on the basis of component, delivery mode, end-user, and region. As per our analysts, mounting preference among healthcare industry to reduce operating cost has increased the demand of the global healthcare supply chain management market. However, there are several factors such as hidden costs, drug shortage, and data storage are the factors that are expected to restrain the market growth. For example, providers in healthcare industry are focused mainly on the product cost and shipping cost. However, there are other expenses such as inventory holding cost.

The Software Component Type is expected to observe lucrative growth in the forecast period

Based on the component, the global market is divided into hardware and service. Among these, software component type is anticipated to observe lucrative growth till 2027. Rising number of people purchasing products online and digitalized payment methods has enhanced the demand of the software segment in the global market. In addition, technological advancements such as utilization of AI along with software development are predicted to enhance the development of the software component segment.

The On-Premise Deliver Mode Segment is anticipated to Dominate the Market in terms of Revenue Generation

Based on the delivery mode, the global healthcare supply chain management market is fragmented into on-premise, cloud based, and web-based. Among these, the on-premise delivery mode segment is anticipated to dominate the market in terms of revenue. Healthcare industry prefer on-premise delivery mode that has enhanced the demand of this segment. However, cloud segment is also predicted to rise with healthy CAGR owing to the ability to share data between organizations and it also helps it integrate the data from multiple locations with ease.

Manufacturers End-User type is expected to have Rapid Growth till 2027

Based on the end-user, the global healthcare supply chain management market is divided into healthcare providers, distributors, manufacturers, and logistics. The manufacturers are anticipated to grow with healthy CAGR till 2027. Constant rise in the demand of healthcare products from patients, distributors, and hospitals, and rise in the demand of the manufacturers are anticipated to look forward to adopt the service of supply chain management that helps to fulfill the needs at reduced cost.

Regional Outlook and Major Market Players

The global healthcare supply chain management market is studied across North America, Europe, Asia-Pacific, and LAMEA. Among these, the North America region is the major revenue generator in the forecast period. North America region is concentrating more on the healthcare industry to offer better hospitality to patients owing to the rise in the awareness among quality of healthcare treatment.

There are several players in the global market but major key-players in the global market includes Manhattan Associates, Blue Yonder Group Inc., Cerner, Jump Technologies, Logi Tag Systems, Harris Affinity, Premier, Accurate Info Soft, Hybrent, Arvato Systems, and others.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Emerging Trends: Why Dynamics of Platelet-Rich Plasma (PRP) Market Is Changing Drastically? What If History Is Any Guide?

     

The chaos of COVID-19 is expected to impact the global platelet rich plasma market in the positive direction. Pure PRP accounted for highest market share in the previous years and orthopedics segment held the significant revenue share in 2019. Also, Asia-Pacific is expected to have most lucrative growth opportunities in the coming years. The key market players are executing various growth approaches to reinforce their foot print in global industry.

The coronavirus emergency has positively affected the global platelet rich plasma market and is expected to experience a remarkable growth in the coming years. During the emergency period, most of scientists and medical professionals are emphasizing their research to find efficient and possible treatment method for the COVID-19. They found plasma therapy is the one of the possible way of treating virus affected people and observed better results in the patient’s recovery through plasma therapy. This factor is eventually driving the market growth in the coronavirus pandemic time.

Furthermore, several government bodies are implementing various activities to help the businesses in the emergency time. For example, in current times, government of China has been encouraged the state owned enterprises (SOEs) to utilize technologies such as latest manufacturing and digital solutions to accelerate the sales and manufacturing activities after lockdown period. Also, government has released new grants for emerging sectors like internet of things, artificial intelligence and machine learning technologies in central SOEs as well as emphasize improvements in areas like healthcare and pharmaceutical products advancements.

Market Research

As per new study conducted by Research Dive, the global platelet rich plasma market is anticipated to generate a revenue of $824.7 million by 2027. The global market is classified into product, application and region. This report gives complete analysis about drivers, opportunities, restraints, segmental analysis and major market players in the global market.

Factors affecting the market growth

As per our analysts, increasing prevalence of orthopedic conditions along with increasing utilization of platelet rich plasma in cosmetic operations are projected to drive the market growth in the forecast years. But, huge costs associated with the treatment of procedures is expected to limit the platelet rich plasma market growth in the projected time.

Leukocyte-rich fibrin product will be the most profitable in the forecast time

The global market classification has been done on the basis of product into pure PRP, leukocyte-rich PRP and leukocyte-rich fibrin. In these, pure PRP segment generated for majority of the platelet rich plasma market share in the previous years and is estimated to continue its growth during the forecast time. This dominance is majorly owing to extensive usage of pure PRP products due to it has brilliant property of removing red blood cells. Besides pure PRP, leukocyte-rich fibrin product will experience a significant growth and is expected to rise at a highest rate during the estimated period. Growing utilization of leukocyte-rich fibrin in surgeries because it contains best healing proteins, which accelerate healing power for muscle generation and strong bones. This factor is expected to fuel the market growth in the projected time.

Orthopedics application held the global market size in previous years

Based on application, the global market has been classified into orthopedics, cosmetic surgery & dermatology, ophthalmic surgery, neurosurgery, general surgery and others. Among these, orthopedics application accounted for highest platelet rich plasma market size in the previous years and is projected to continue its growth in the coming years. The wide utilization of platelet rich plasma in orthopedic application due to its enhances the healing power of bones, which will drive the market growth in the estimated time. Also, cosmetic surgery & dermatology application will witness to rise at a significant rate and is projected to generate highest revenue during the forecast period. Increasing trend for facial appearance enhancement treatments is expected to boost the platelet rich plasma procedures, which will drive the market growth in the coming years.

Platelet rich plasma market, Regional analysis

The global platelet rich plasma market has dominated by North America region in the previous years and is projected to remain its dominance over the global market in the forecast time. Presence of well-established healthcare infrastructure and growing application of platelet rich plasma in orthopedic surgeries due to increasing elderly people across the North America region is expected to drive the market size in the forecast years. Along with North America, the market for Asia-Pacific market will witness to grow at a faster rate and is projected to generate significant growth opportunities in the global market during the forecast time. This expected growth is attributed to increasing government investments on the up-gradation of healthcare facilities along with growing cosmetic surgeries to improve facial features across the Asia-Pacific countries.

Significant market players in the global platelet rich plasma market

The significant players in the global platelet rich plasma market are Arthrex, Inc., Glofinn Co. Ltd., Stryker Corporation, ISTO Biologics, Exactech Inc., Zimmer Biomet, DePuy Synthes, Inc., AdiStem Ltd., Cesca Therapeutics, Inc. and Nuo Therapeutics.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Advancement: MRI Guided Neurosurgical Ablation Market by Top Key Players, Applications and Forecast to 2020-2027

     

The emergency of COVID-19 has a notable effect on the global MRI guided neurosurgical ablation market. Accessories segment accounted for significant market size in the previous years and hospitals segment contributed majority of the revenue share in 2019. Also, North America region has dominated the global market share in the previous years. The key market players are continuously increasing their efforts to improve the product performance to gain major position in the global market.

This outbreak of COVID-19 has considerable impact on the global MRI guided neurosurgical ablation market growth in 2020. According to World Health Organization (WHO) has officially announced, the novel coronavirus does not seem to affect the spinal cord, peripheral nerves and brain. However, the pandemic created shortage of essential life saving devices such as medical devices & accessories as well as many other important medical supplies. These factors are eventually affecting the MRI guided neurosurgical ablation market growth in 2020.

Furthermore, prominent market players are adopting several strategies such as joint ventures and acquisitions to strengthen their presence in the overall industry. For instance, in February 2020, Medtronic, global leader in medical technology, has announced the acquisition of Digital Surgery, which is the leading organization in surgical AI, and digital training and education. This acquisition has made to reinforce the Medtronic robotic assisted surgery platform and has beneficial for the Medtronic portfolio. Surgical AI and digital surgeries platforms are playing a crucial role in advancing minimally invasive surgery treatment methods.

Market Research

During this unexpected situation, we are providing our clients in understanding the impact of COVID19 on the MRI guided neurosurgical ablation market.

As per new study conducted by Research Dive, the global MRI guided neurosurgical ablation market is projected to reach up to $5.6 million by 2027 and is estimated to witness a noticeable growth in the forecast period 2019 to 2027.

The global market is segmented into product, end use and region. This study delivers comprehensive information of drivers, opportunities, restraints, segmental analysis and major participants in the global market.

Factors affecting the market growth

As per our analysts, increasing demand for non-invasive treatment methods along with growing number of cancer patients across the globe are significantly driving the MRI guided neurosurgical ablation market growth. However, dearth of work forces for neurosurgical treatments and high treatment costs are expected to restrict the market growth.

Accessories product and hospitals end use segments are expected to have dominating market share in the forecast years

Based on product, the global market has been segmented into MRI-guided focused ultrasound systems, radio frequency ablation systems, accessories and laser ablation systems. Among these, accessories product type accounted for highest MRI guided neurosurgical ablation market size in 2019 and is predicted to continue its trend in the coming years. Operating rooms requires specific medical accessories to perform surgeries and without the right accessories, the surgeons may struggle to deliver the better quality care and customer service. These factors are fueling the demand for accessories and is expected to drive the market growth in the projected time.

The global market has been categorized on the basis of end use into ambulatory surgical centers, clinics and hospitals. Among these, hospitals segment accounted for dominating market share in 2019 and is estimated to continue its growth at a notable rate throughout the projected timeframe. Hospitals contains special division for neurosurgical department, experienced neurosurgeons and well equipped neuro surgical equipment’s. Thus, most of the people are preferring hospitals for positive results even in complicated treatments. These factors are driving the market growth in the forecast years.

MRI Guided Neurosurgical Ablation Market, Regional outlook

The global MRI guided neurosurgical ablation market size has dominated by North America region in 2019 and is predicted to retain its growth in the global market throughout the forecast years. Existence of well-established healthcare facilities and presence of highly experienced neurosurgeons in the North America region, this actor is expected to drive the market growth in the forecast time. Along with North America, Europe region accounted for second highest market share in the previous years and is estimated to grow at a faster rate during the projected period. This expected growth attributed to growing adoption of invasive treatment methods due to rise prevalence of neurosurgical disorders in the Europe region.

MRI Guided Neurosurgical Ablation Market, Key market players

The significant players in the global MRI guided neurosurgical ablation market are ClearPoint Neuro, Inc., Monteris, Boston Scientific Corporation, MRI Interventions, Inc., INSIGHTEC Ltd, AngioDynamics and Medtronic among others.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Competitive Scenario: Mechanical Ventilators Market by Key Driver, Challenges and Opportunities 2027

     

The Community transmission of coronavirus disease (COVID-19) has created a noteworthy impact on the global mechanical ventilators market, during the forecast period. Moreover, the critical care segment has significant market growth in the global market. The Asia-Pacific region will create multiple opportunities for investments during the projected period. The leading companies of the mechanical ventilators market are concentrating on various strategies to sustain in the outbreak of COVID-19.

The COVID-19 pandemic has created a great impact on mechanical ventilators in the global market. The sustainability of the global market technological upgradations, surge in the geriatric population, and rising prevalence of chronic diseases across the nations. However, the businesses around the world have implemented a complete shutdown in order to prevent the spread of COVID-19, the companies operating in mechanical ventilators market are continuously working to support the community. In addition, key manufacturers of the mechanical ventilators market are implementing strategic plans such as strategic collaborations, product development, and technological innovations to strengthen the position in the global marketplace.

For instance, in April 2020, WEG, leading industrial electric motor manufacturer, has passed the technology transfer agreement with LEISTUNG Equipamentos Ltda. For the manufacturing of artificial ventilators. In addition to this, the government authorities are also supporting through grants, product approvals to these players, amid the COVID-19. For instance, in July 2020, Getinge, the global medical technology company, has received 510(k) approval from the U.S. Food & Drug Administration (FDA) for the Servo-air mechanical ventilator. These ventilators play a key role in the treatment of adult and pediatric patients. These factors are expected to create enormous opportunities for the global mechanical ventilators market, during the pandemic crisis. The report is designed to guide key-players in strategic, operational, and financial planning over the next coming years.

Market Research

According to the study report published by Research Dive, the global mechanical ventilators market is set to register a revenue of $2,892.5 million by 2027, at a healthy CAGR during the analysis timeframe.

The segmentation of the global mechanical ventilators market has been done based on the product and region. The report provides key insights on drivers, segments, future opportunities, restraining factors, and key manufacturers of the global market.

The Factors Affecting Market Growth

As per our analyst estimates, the technological advancements, increasing prevalence of chronic disorders are fueling the global Mechanical ventilators market growth. However, health complications and the higher prices of mechanical ventilators are expected to restrain the growth of the global mechanical ventilators market, throughout the forecast timeframe.

Critical Care Segment Will be the Most Lucrative

Based on the product, the global mechanical ventilators market is categorized into neonatal, critical care, and transport & portable. The critical care segment shall have rapid growth, in the analysis period; due to high efficiency, cost-effectiveness, and excellent reliability.

Geographical Analysis and Major Market Players

Depending on the region, the global mechanical ventilators market is divided into North America, Asia-Pacific, Europe, and LAMEA. The Asia-Pacific mechanical ventilators market is expected to rise at a remarkable CAGR throughout the analysis period. The increasing healthcare supportive policies for the development of infrastructure and rising R&D and innovations mainly into, China, Japan, and South Korea are projected to propel the growth of the market, in the region.

The significant players of the global mechanical ventilators industry include Drägerwerk AG & Co. KGaA, Medtronic, Smiths Group plc, Teleflex Incorporated, Koninklijke Philips N.V., ResMed, Getinge AB, Bunnell Incorporated, VYAIRE, and GENERAL ELECTRIC COMPANY.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Growth Outlook: Cardiac Pacemakers Market – Future Growth, & Forecast to 2027

     

The cardiac pacemakers market is predicted to grow in terms of revenue in the forecast period. Increasing cardiovascular diseases is predicted to be the major driving factor for the market in the estimated period. Dual chamber pacemaker is predicted to hold the highest market share. Europe region is predicted to create more investment opportunity for the investors to invest in the projected timeframe.

The cardiac pacemakers market is predicted to generate maximum revenue in the forecast period. Increasing cases of cardiovascular diseases among the people and rise in the geriatric population is predicted to be the major driving factor for the cardiac pacemakers market in the forecast period. Moreover, government initiative in healthcare sector is predicted to drive the market in the forecast period. For instance, In March 2019, The Agency for Healthcare Research and Quality (AHRQ) has partnered with hospitals and healthcare systems to take the initiative and train them to improve the use of cardiac rehabilitation and obtain enhanced benefits. On the other hand, higher treatment cost is predicted to hamper the market growth in the forecast period. During this lockdown most of the healthcare institution focus on treating COVID patients and most of the equipment are used for treating the increasing cases of COVID due to which it is predicted to hamper the market growth in the 2020 For instance, In July FDA approves Abbott’s Bluetooth-connected pacemaker, defibrillator implants. Abbott has secured approvals from the FDA for its new generation of connected pacemakers and defibrillator implants. During this unpredicted situation, we are helping our clients in understanding the impact of COVID19 on the global cardiac pacemakers market.

According to a study conducted by Research Dive, the global cardiac pacemakers market is expected to register a revenue of $3.78 billion by 2027.

The global market is classified on the basis of product and end-use industry. The report offers the complete information about drivers, opportunities, restraints, segmental analysis and major players of the global market.

Factors Affecting the Market Growth

As per our analyst, increasing cardiovascular diseases among the population and rise in the geriatric population is predicted to be the major driving factor for the global cardiac pacemakers market in the forecast period. On the other hand, high treatment cost along with low awareness about the cardiovascular diseases is predicted to hamper the global cardiac pacemakers market in the forecast period.

Market Research

Dual Chamber Pacemaker is Predicted to Grow Enormously

On the basis of product, the cardiac pacemakers market is further classified into single chamber pacemaker, dual chamber pacemaker and CRT pacemaker. Dual chamber pacemaker is predicted to grow enormously in the forecast period. Cost effective way of treating cardiovascular disease which ensure normal working of heart is predicted to drive the segment in the forecast period.

Clinic and Hospitals Segment is Predicted to Have the Maximum Growth Rate

On the basis of end user, the cardiac pacemakers market is further classified into clinic and hospitals, ASC’s and others. Clinic and hospitals segment is predicted to have the maximum growth rate in the forecast period. Increased availability of equipment to treat cardiovascular treatment and surgeries which improve the quality of care is predicted to boost the segment in the forecast period.

Regional Breakdown of the Market

On the basis of region, the cardiac pacemakers market is further classified into North America, Asia-Pacific, Europe and LAMEA. Europe region market is predicted to have the highest market share in the forecast period. Increased awareness among the population about the cardiovascular diseases and increased developed healthcare infrastructure is predicted to boost the region market in the forecast.

Top Companies Leading the Market

The major key player in the market are BIOTRONIK SE & Co. KG, Boston Scientific Corporation Medtronic, Abbott, LivaNova PLC, lepumedical.com, Osypka Medical GmbH, Pacetronix.com, MEDICO S.p.A., and OSCOR Inc among others.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Regional Outlook: Antiviral Therapies Market by Key Vendors, Challenges and Opportunities 2027

Global Antiviral Therapy Market size is expected to grow with a CAGR of 5.8% from 2019 to 2026 According to a study conducted by Research Dive. The global antiviral therapy market size was accounted at $48.1 billion in 2018 and is anticipated to garner $ 75.6 billion by 2026.

Increasing incidences of viral infections, growing awareness among public about these infections, rise in healthcare spending, growing R&D investments, and growing incidences of severe and deadly disorders in people are the key antiviral therapy market drivers responsible to boost the growth of global market during estimated period. In addition, development of broad-spectrum antibiotics and surge in profitable opportunities in the developing economies of Asia-Pacific and LAMEA regions are expected to provide numerous opportunities for the growth of the market. On the other hand, huge costs involved in the manufacturing of these therapy and rise in the demand for alternative medicines such as homeopathy and naturopathy are expected to restrain the development of the market.

The HIV segment in the antiviral therapy market was valued at $16.4 billion in the year 2018 and is expected to increase with a growth rate of 5.4% throughout the estimated period. This is because of the rising occurrence of HIV infection across the globe. The majority of HIV antiviral drug usage has been seen in the North America region. Also, the consumption of antiviral therapy in African region is expected to increase and fuel the development of the market.

The online pharmacy segment is expected to grow at an increased speed by generating a revenue of $23.2 billion by the end of 2026, at a significant growth rate of 6.1% during the forecast period. On the other hand, the hospital pharmacy segment is anticipated to dominate the market by generating a revenue of $35.5 billion by the end of 2026, at a substantial growth rate of 5.5% throughout the forecast period. This is mainly due growing trends in the online shopping sector in the developed and developing countries. At present, the market share is mainly controlled by a few top pharmaceuticals as well as biotechnology companies.

Regionally, the market has been studied across Asia-Pacific, North America, Europe, and LAMEA. Asia-Pacific antiviral therapy market is anticipated to grow at an increased pace with a healthy growth rate of 6.5% during the forecast period, garnering $12.8 billion by the end of 2026. This is mainly due to factors such as the growing cases of HIV infection, growing awareness about HIV infection, and increasing collaboration between public and private sectors in this region. Furthermore, the North America antiviral therapy market held a leading position in the global antiviral therapy market in 2018. This region is anticipated to hold its lead position in the market throughout the forecast period by generating a revenue of $29.5 billion by 2026. This is attributed to factors such as the rising occurrence of HIV and hepatitis C infections, well-established market players in the region, growing healthcare awareness, rising elderly population, and increasing healthcare spending in this region. On the contrary, factors such as patent expiration and generic erosion of antiviral therapy are hindering the growth of the market in this region.

The key market players profiled in the report are F. Hoffmann-La Roche Ltd., Gilead Sciences, GlaxoSmithKline, Abbott Laboratories, AbbVie Inc., AstraZeneca Plc., Bristol- Myers-Squibb, Johnson & Johnson, Schering-Plough Corporation, and Merck & Co., Inc. These market players are undertaking several activities to grab a major share of the market and hold a leading position in the antiviral therapies industry. Some of these activities include new product launches, mergers and acquisitions, antiviral therapy market developments in current technology. These are some of the growth strategies implemented by these market players.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Industry Verticals: 3D Cell Culture Market Set For Rapid Growth & Trend, By 2027

According to a study of Research Dive, global 3D Cell Culture market forecast shall cross $12,638.8 million by 2026, growing at a CAGR of 29.4 during forecast period.

3D Cell culture is an essential tool in clinical analysis and biological science. It has multiple applications such as in biosensors, drug screening and others. Many improvements have been made in automated high-throughput cell culture systems. Increasing demand for regenerative medicine and economic drug discovery is expected to drive the demand for the 3D cell culture market. 3D cell cultures are primarily used to observe the abnormal behavior of cells and the cell-cell interaction. Furthermore, 3D cell culture systems play a significant role in the development of precision medicine and personalized medicine. For instance, as per study of cancer researchers (University of Michigan) newly invented 3D structure could enable physicians to test medications on model tumors grown from a patient’s own cells. These advances are projected to boost the growth of global cell culture market. However, more complex culture system, added expenses and threats from substitutes like 2D cell cultures are projected to limit the 3D cell culture market growth.

With new advances, 3D composite scaffolds have many versatile properties. It will be tremendously useful to develop treatments for nerve disorders and spinal cord injury (SCI) by taking help of cell transplantation methodologies and biomaterials. The most remarkable advantage of 3D cell culture is, their properties can be easily adapted by modifying the structure and composition. These key factors of 3D cell culture are projected to create enormous opportunities for the growth of 3D cell culture industry.

According to Analyst Evaluation, Microchips market shall register a revenue of $2,515.5 million by the end of 2026, growing at a CAGR of 30.1% during the forecast period; this is significantly due to new advances in 3D culture ‘organs-on-chips’. Organs-on-chips allow study of human physiology and also reveal development of novel in vitro disease models. It could provide potential replacements for animals used in toxin testing and drug development. These advancements are anticipated to grow the demand of microchips in global market, and are projected to boost the global market. Scaffold-based platforms have the largest market share and this segment will register a revenue of $3,425.1 million by the end of 2026, growing at a CAGR of 28.4%. Scaffolds can be significantly used in drug development therapeutic or specialty areas; which is anticipated to fuel the of global market growth.

Based on applications, the market is segmented into Stem Cell research, drug discovery, cancer research, and regenerative medicine. 3D cell culture market size for cancer research will generate a revenue of $4,057.1 million by 2026, growing at a CAGR of 28.5% throughout the forecast period; this is majorly due to various types of cancers such as breast cancer, lung cancer and others being dominant among the population. Cancer has a pervasive prevalence across the globe, which has led to rise in demand for cancer research, which is further attributed to boost the demand for 3D cell culture market. 3D cell culture market for regenerative medicine will register a revenue of $3,690.5 million by 2026, growing at a CAGR of 30.1%. Many developed and developing countries such as Japan is focusing more on contract manufacturing tie-ups, and continues to be a lucrative place for biotech ventures to do business. Japan is the world leader in regenerative medical products; these key strategies of the government are anticipated to spur the growth of 3D cell culture market.

3D cell culture market for biotechnology & pharmaceutical companies will register a revenue of $5,184.4 million by 2026, growing at a CAGR of 28.9% during the forecast period; this is majorly due to huge developments in the laboratory, technology and operations. Furthermore, rising pressure on sales of established treatments, rapid growth of cell therapies and focus on advanced manufacturing and technologies are the factors expected to grow the market.

North America 3D Cell Culture market size will cross $4,019.1 million by 2026, increasing at a healthy CAGR of 28.1%.

Heavy investments in research & development, high healthcare expenditure, and extensively increasing number of cancer cases are considered to be one of the driving factors that are booming the growth of North American market.

3D Cell Culture market share for Asia-Pacific region is expected to rise at a CAGR of 30.7% by generating a revenue of $3,020.7 million by 2026. The market growth in the region is increasing drug discovery initiatives among pharmaceuticals and biotechnology companies in the region. Major economies such as India, Singapore, Japan and South Korea are emphasizing more on public sector openness to partnership with established companies. For instance, leading market players such as Bayer, GlaxoSmithKline and AstraZeneca are collaborating with Singapore partners across drug discovery.

The major 3D Cell Culture manufacturers include QGel SA, Hµrel Corporation, SynVivo, Greiner Bio-One International, Advanced BioMatrix, Lonza, Corning Incorporated, Thermo Fisher Scientific, TissUse GmbH, 3D Biotek. Players using updated technologies for their 3D Cell Culture will have good probability of having success in the rapidly blooming market. For example, Lonza has innovated the RAFT 3D Culture System that produces hepatocytes with increased stability and stronger cytochrome responses.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Emerging Trends: Therapeutic Obstructive Sleep Apnea Device Market Sees Promising Growth in 2020

Global Therapeutic Obstructive Sleep Apnea Device market was valued at $ 4,661.6 Million in 2018 and is expected to reach of $ 9,561.3 Million by 2026, growing at a CAGR of 9.6% over the forecast period.

Obstructive sleep apnea is caused due to the blockage of the airways. This happens during sleep when the tongue folds with the soft palate and stops the air to pass on against the throat. It is being estimated that most of the mid age population tends to experience obstructive sleep apnea more than 5 times in half an hour.

Increasing number of cases in the sleep apnea is expected to drive the market for the therapeutic obstructive sleep apnea devices. It has been estimated that, around 80% of the patient who are suffering from obstructive sleep apnea are not being treated. The ratio between the total number of patients facing the obstructive sleep apnea and the patient who is being diagnosed is very minimal, so rising awareness among the patient can lead to the growth of the therapeutic obstructive sleep apnea market. Lack of awareness regarding the effects caused due to the obstructive sleep apnea such as, high blood pressure, diabetes, obesity and sometime the death of the patient may occur due to negligence and unawareness. Government initiative to raise the awareness among the people and the advanced technologies expected to give a boost to the overall obstructive sleep apnea therapeutic devices market.

The main reason for dissension of therapeutic obstructive sleep apnea devices is due to the lack of acceptance from the patients, this is mainly due to the discomfort and anxiety caused by the mask. The cost of therapeutic obstructive sleep apnea devices market is very high as compared to the other sleep apnea disease. The cost is the main constraint for the increase of the therapeutic obstructive sleep apnea devices market.

Depending on the type the positive airway pressure segment held the largest market size in 2018 for $2,187.8 million and is expected to reach $4,542.3 million by 2026, at a CAGR of 9.7%. Positive airways reduce the sleep apnea occurrence and protect the airways from closing. The oral application is estimated to grow at 9.5% CAGR by generating revenue by $1,768.2 million by 2026. It is expected to offer patient with greater satisfaction. Oral applications are portable, flexible and easy to use, so American Academy of Sleep Medicine (AASM) suggested to wear oral application with severe obstructive sleep apnea, who cannot wear and use positive airway pressure.

Due to the rising number of hospitals and growing investment in healthcare the hospitals and sleep laboratories segment is anticipated to drive the market over the forecast period. Hospitals and sleep laboratories segment accounted for $2,569.3 million in 2018 and is expected to rise at a CAGR of 9.4% in the forecast period.

North America holds the largest market share for the therapeutic obstructive sleep apnea devices market. This region registered 10.2% CAGR and is anticipated to generate a revenue of $3,970.7 million by 2026. The Asia-Pacific is the largest growing market for the therapeutic obstructive sleep apnea devices as most of the Asian countries are not developed in the medical facilities and are unaware of the therapeutic obstructive sleep apnea devices. It is projected that the region sleep apnea devices market is expected to grow at $1,777.7 million by 2026 at a CAGR of 9.0%.

The major key players in the therapeutic obstructive sleep apnea devices market are Invacare Corporation GE Healthcare, Compumedics Limited, BMC Medical Co., Fisher & Paykel Healthcare, Cadwell Laboratories Inc., Ltd, Braebon Medical Corporation, Becton Dickinson (CareFusion Corporation), Curative Medical Inc., ImThera Medical, Inc.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Opportunities: Breast Implant Market Scope by Demand, Trends to Expand Significantly by 2027

Breast Implant Market size will exceed $4.9 Billion by 2026, growing at a CAGR of over 10.3% from 2019 to 2026; according to a new research study by Research Dive.

An increase in the number of breast augmentation processes, along with the rise in breast cancer incidences across the world will significantly drive the global breast implant market size over the forecast period. The breast augmentation processes enable women to improve their breast size, and also to improve their hip contour balance. These are also called as reconstruction procedures, which help to restore the breasts’ size to near normal size. They also help in improving the appearance of the breasts. Rapid growth in these procedures will significantly spur the global breast implant market growth during the projected timeline.

Rapid growth in the incidences of breast cancer across the world will boost the growth of breast implant market growth in the coming years. As a result of this, the majority women are preferring mastectomy procedures during their breast cancer treatment.

However, the high cost of implantation procedures, coupled with the rising implications post-surgeries will impede the breast implant market growth.

The silicone breast implant market size held the largest share in 2018 and is projected to grow at a CAGR of over 10.2% over the projected timeframe. The dominant market size is expected throughout the forecast period, owing to the product’s capability to look natural. Some of the other benefits such as reduced wrinkling will further provide a significant boost to product adoption.

The breast implant market for reconstruction procedure will increase at a CAGR of more than 10.7% during the projected period. This is majorly due to the increasing incidences of breast cancer, and also to avoid them. An increase in awareness about reconstruction surgery to overcome the cancer incidences has resulted in significant growth in procedure adoption.

The majority of the patients are preferring clinics as their place of surgery. This is majorly due to the presence of skilled professionals, coupled with the less cost associated with the comparison with the hospital sector. Breast implant procedures in clinics will grow at a CAGR of over 9.8% during the projected period. Expanding infrastructure in the healthcare sector in the emerging economies will further enhance the market growth. This segment will further grow on account of the availability of skilled plastic surgeons in the clinics.

North America market held a significant market share in 2018 and accounted for more than 40% in 2018. An increase in the number of the female population preferring the augmentation procedures will further drive the market growth. Growth in per capita expenditure, coupled with the rise in disposable income will further serve to be one of the high impacting factors for the growth of North America breast implant market growth.

The Asia-Pacific market is projected to witness a robust growth at 11.0% CAGR during the forecast period. The rise in the number of hospitals and clinics offering plastic surgery procedures, coupled with the increase in the number of plastic surgeons in this region will enhance the regional market growth during the coming years.

Some of the prominent companies in the global breast implant market include GC Aesthetics, Allergan, Mentor Worldwide LLC, Laboratoires Arion, Groupe Sebbin, Hansbiomed Co. Ltd., Sientra Inc., Silimed, Groupe Sebbin SAS, and CEREPLAS among many others. Some of the strategies preferred by the operating companies are product development and acquisitions.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Autotransfusion Devices Market Is Expected To Grow with a Healthy CAGR During 2020-2027

According to a recent report published by Research Dive, titled, “Autotransfusion Devices Market by Type, and Application: Global Opportunity Analysis and Industry Forecast, 2018-2027,” the global autotransfusion devices market size was $1,121.5 million in 2018, and is anticipated to reach $1,939.7 million by 2027, at 6.5% CAGR from 2019 to 2027.

The North America regional market dominates the global market, followed by Europe, Asia-Pacific, and LAMEA. U.S. dominated the global autotransfusion devices market share in 2018, and is expected to grow at a significant rate during the forecast period.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of autotransfusion: Blood can be autologously “pre-donated” (termed so despite “donation” not typically referring to giving to one’s self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device (such as a Cell Saver or CATS). The latter form of autotransfusion is utilized in surgeries where there is expected a large volume blood loss – e.g. aneurysm, total joint replacement, and spinal surgeries. The device used for autotransfusion is called autotransfusion devices.

Presently, many surgeons utilize autotransfusion innovatively such as with a cell processing step which not only is efficient and less time consuming but also enables the patient to have safe blood transfusion. Moreover changing lifestyles coupled with the increasing obesity amongst the masses has resulted in increased chances of having cardiac diseases which has prompted the growth of Autotransfusion devices.

High occurrence of cardiac diseases leads to the huge demand of auto-transfusion device across the world. Furthermore, absence of any risk of transfusion or transmitted infections is boosting the growth for autotransfusion devices globally. On the contrary, inability to separate contaminants from blood is expected to be a major restraint for autotransfusion devices market. On the other hand, growing Adoption of whole body autotransfusion devices.

Off-Pump Autotransfusion devices holds the highest market share amongst the product type segment and is expected to grow with a CAGR of 6.6% during the forecast period 2019-2027. The driving factor for off-pump transfusion is the device usage ease, coupled with no blood loss feature during the transfusion process. Major trends in the off-pump transfusion is its efficacy and the fact that off-pump transfusion have much lower post-operative morbidity and mortality especially in high risk patients.

Amongst the end use segment, Hospital segment holds the largest market share and is expected to grow at CAGR of 6.6% during the forecast period. This primarily because, the hospitals have specialized departments wherein blood transfusion is required as such the autotransfusion devices are required in multiple numbers to cater to various transfusion requirements of specialized diseases in various department.

 

North America has the highest market share for autotransfusion device globally and is expected to grow at a healthy rate of 6.4% over the forecast period. U.S, hold the majority of the share of the North America market and it is one of the leading countries globally. As the regulatory standards regarding transfusion are quite stringent in U.S., companies are investing a lot on Research & Development for approvals of commercial sale of Autotransfusion device and therefore they are focused on quality and innovative products so as to efficiently handle the process and edge ahead of competitors, thus driving the growth of Autotransfusion device in the country.

One of the prominent players in autotransfusion devices market viz., Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Personalized Closed Loop (PCL) insulin pump system, currently in development. The PCL technology is designed to automate insulin delivery in a way that is real-time, personalized and adapts to the user. The system will also provide insights and predictive diagnostics unique to the individual, with a goal of dramatically simplifying diabetes management for the patient. The recent acquisition of Nutrino Health and their expertise in nutrition data science will play a key role in the accelerated development of this breakthrough technology. Zimmer Biomet Holding, Becton Dickinson and Company, LivaNova, Plc, Teleflex Incorporated, Stryker Corporation, Fresenius Medical Care AG & Co. KGaA, Terumo Corporation, Haemonetics Corporation and Getinge AB.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com